Refresh

GlaxoSmithKline Pharmaceuticals Ltd. - Research Center

500660 GLAXO Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

3,216.34 3,217.51 2,920.48 3,224.68 3,128.53
Expenses

Material consumed

1,255.99 1,300.39 1,252.47 1,308.95 1,361.76

Manufacturing expenses

103.44 121.30 108.04 33.36 27.94

Personnel expenses

594.99 610.23 616.16 628.55 537.20

Selling expenses

- - - 138.23 -

Adminstrative expenses

462.50 429.76 346.03 457.13 595.15

Expenses capitalised

- - - - -

Cost of sales

2,416.92 2,461.68 2,322.70 2,566.23 2,522.05

Operating profit

799.43 755.83 597.77 658.45 606.48

Other recurring income

101.51 76.22 110.19 77.56 101.48

Adjusted PBDIT

900.94 832.04 707.96 736.01 707.96

Financial expenses

1.81 1.99 3.53 6.34 0.55

Depreciation

65.77 68.19 78.60 82.68 48.59

Other write offs

- - - - -

Adjusted PBT

833.36 761.87 625.83 646.99 658.82

Tax charges

227.69 396.87 166.54 212.45 238.35

Adjusted PAT

605.67 365.00 459.29 434.55 420.47

Non recurring items

2.08 1,325.53 -101.72 -324.49 4.89

Other non cash adjustments

- - - - -

Reported net profit

607.75 1,690.53 357.57 110.05 425.36

Earnigs before appropriation

2,352.77 2,253.24 1,240.34 1,291.23 1,538.57

Equity dividend

1,524.66 508.22 677.62 269.17 235.52

Preference dividend

- - - - -

Dividend tax

- - - 69.64 60.94

Retained earnings

828.12 1,745.02 562.71 952.41 1,242.11
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com